Peripheral neuropathy: A persisting challenge in paclitaxel-based regimes
- 1 January 2006
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (1) , 24-30
- https://doi.org/10.1016/j.ejca.2005.06.030
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced MalignanciesClinical Cancer Research, 2004
- Cremophor ELEuropean Journal Of Cancer, 2001
- Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: an In Vitro StudyJNCI Journal of the National Cancer Institute, 1998
- Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapyEuropean Journal Of Cancer, 1997
- Paclitaxel-induced neuropathyAnnals of Oncology, 1995
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studiesAnnals of Neurology, 1994
- Hypersensitivity reactions from taxol.Journal of Clinical Oncology, 1990
- Taxol produces a predominantly sensory neuropathyNeurology, 1989
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971